Featured on Forbes: The synthetic biology companies racing to fight the coronavirus

2020-02-05

AbCellera has been listed alongside a suite of other biotechnology companies, including Moderna, GenScript, and Mammoth Biosciences, that are actively responding to COVID-19. Under the DARPA Pandemic Prevention Platform (P3) program, AbCellera is working to rapidly identify antibodies that can neutralize the virus and potentially block its transmission.

Read full coverage on Forbes.